Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × telotristat ethyl × Clear all

Phase

Status

Withdrawn 3 Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 140 Docetaxel 132 Carboplatin 129 Bevacizumab 129 pembrolizumab 124 Radiotherapy 116 Gemcitabine 116 Cisplatin 115 Paclitaxel 114 Capecitabine 101 Rituximab 99 Fluorouracil 93 Oxaliplatin 88 Irinotecan 77 Nivolumab 76 Leucovorin 74 Doxorubicin 71 Dexamethasone 69 Pemetrexed 66 fludarabine 62 Etoposide 60 fludarabine phosphate 58 Bortezomib 57 Erlotinib Hydrochloride 55 Methotrexate 52 Cytarabine 52 Cetuximab 52 Trastuzumab 48 Sorafenib 43 Prednisone 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03790111 2023-04-19

TELE-ABC

TerSera Therapeutics LLC

Phase 2 Terminated

53 enrolled 47 charts

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡